Clinical Trial Detail

NCT ID NCT00957853
Title Preoperative Treatment With Cetuximab and/or IMC-A12
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Cixutumumab

Age Groups: adult

No variant requirements are available.